XML 91 R55.htm IDEA: XBRL DOCUMENT v3.25.1
Segment information (Tables)
 12 Months Ended
Dec. 28, 2024
Segment Reporting [Abstract]  
Schedule of Segment Information
The following tables present our segment information (in $000’s):
For the Years Ended
December 28, 2024December 30, 2023
Revenue
Fintech$12,532 $— 
Biotech— — 
Corporate and other— — 
Discontinued operations— 3,795 
Total Revenues$12,532 $3,795 
Gross profit
Fintech$6,294 $— 
Biotech— — 
Corporate and other— — 
Discontinued operations— (197)
Total Gross profit$6,294 $(197)
Operating loss
Fintech$905 $— 
Biotech(2,148)(1,531)
Corporate and other(6,319)(18,315)
Discontinued operations— 10,438 
Total Operating loss$(7,562)$(7,562)$(9,408)
Depreciation and amortization
Fintech$1,316 $— 
Biotech2,086 1,452 
Corporate and other— — 
Discontinued operations— 96 
Total Depreciation and amortization$3,402 $1,548 
Interest (expense) income, net
Fintech$(499)$— 
Biotech— — 
Corporate and other(380)2,250 
Discontinued operations— (181)
Total Interest (expense) income, net$(879)$2,069 
Net loss after provision for income taxes
Fintech$469 $— 
Biotech(2,086)(1,532)
Corporate and other(4,628)(15,563)
Discontinued operations— 9,283 
Total net loss after provision for income taxes$(6,245)$(7,812)
As of
December 28, 2024		As of
December 30, 2023
Assets
Fintech$64,217 $— 
Biotech16,926 17,846 
Corporate and other1,293 641 
Discontinue operations— — 
Total Assets$82,436 $18,487 
Goodwill and other intangible Assets
Fintech$30,385 $— 
Biotech15,755 17,846 
Corporate and other4 — 
Discontinued operations— — 
Total goodwill and other intangible Assets$46,144 $17,846